1. Home
  2. PL vs EXEL Comparison

PL vs EXEL Comparison

Compare PL & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$35.26

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$44.36

Market Cap

11.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PL
EXEL
Founded
2010
1994
Country
United States
United States
Employees
970
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
11.4B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
PL
EXEL
Price
$35.26
$44.36
Analyst Decision
Buy
Buy
Analyst Count
13
21
Target Price
$24.34
$46.45
AVG Volume (30 Days)
15.7M
2.0M
Earning Date
03-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.95
EPS
N/A
2.78
Revenue
N/A
$452,477,000.00
Revenue This Year
$41.85
$13.66
Revenue Next Year
$29.44
$13.39
P/E Ratio
N/A
$16.33
Revenue Growth
N/A
N/A
52 Week Low
$2.92
$33.76
52 Week High
$38.21
$48.74

Technical Indicators

Market Signals
Indicator
PL
EXEL
Relative Strength Index (RSI) 59.73 59.36
Support Level $5.84 $40.53
Resistance Level $37.05 $45.88
Average True Range (ATR) 3.67 1.04
MACD 0.26 0.34
Stochastic Oscillator 72.16 76.11

Price Performance

Historical Comparison
PL
EXEL

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: